Skip to main content
HURA logo

TuHURA Biosciences, Inc.

HURANASDAQHealthcareBiotechnology

$1.76Today:- (-)1Y −23.75%

As of Oct 16, 2026 close

Market cap
$117.05M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.41$3.43
Volume (live)
-
Avg. volume (3M)
210.67K

TuHURA Biosciences (HURA) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), TuHURA Biosciences reported total assets of $27.35M and total liabilities of $6.42M. Shareholders' equity was $20.93M, up 43.4% from $14.59M a year earlier. Total debt stood at $700.02K against $3.62M in cash and short-term investments, a net cash position of $2.92M. That puts debt-to-equity at 0.03, compared with 0.01 a year earlier.

TuHURA Biosciences Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for TuHURA Biosciences, Inc. (HURA) - Annual data in millions USD
BreakdownFY 2025FY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018
Period endingMar 2026Dec 2025Mar 2025Dec 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Jun 2020Jun 2019Jun 2018
Current Assets
Cash and Cash Equivalents3.623.6212.6612.663.673.6714.2514.255.555.5510.542.393.72
Cash & Short-Term Investments3.623.6212.6612.663.673.6714.2514.255.555.5510.542.393.72
Accounts Receivable0.000.500.220.640.330.330.100.10-0.000.000.000.03
Inventory0.00-0.21--0.00-0.00-0.000.000.000.00
Other Current Assets1.000.506.526.951.740.160.490.390.140.141.260.370.28
Total Current Assets4.624.6219.6119.614.164.1614.7414.745.685.6811.792.764.03
Non-Current Assets
Property, Plant & Equipment (Net)0.690.690.320.320.710.200.420.420.620.620.150.000.00
Goodwill10.7410.740.00--0.00-0.00-0.000.000.000.00
Intangible Assets0.0011.280.00--0.00-0.00-0.000.000.000.01
Other Non-Current Assets11.310.030.030.03-0.000.030.030.100.101.600.180.00
Total Non-Current Assets22.7322.730.360.360.200.200.450.450.720.721.750.180.01
Total Assets27.3527.3519.9719.974.364.3615.2015.206.406.4013.542.944.04
Current Liabilities
Accounts Payable3.775.523.155.173.081.871.921.920.410.412.222.011.74
Short-Term Debt0.400.200.16--0.02-0.120.640.640.000.000.00
Accrued Liabilities-0.23-2.021.57-0.16-0.04----
Other Current Liabilities1.75-2.02-0.141.71-0.84-6.090.560.660.33
Total Current Liabilities5.925.925.335.333.083.602.872.877.157.152.782.682.07
Non-Current Liabilities
Long-Term Debt0.300.300.040.042.322.320.020.02-0.000.000.000.00
Deferred Tax Liabilities0.200.200.00--0.00-0.00-0.000.000.000.00
Other Non-Current Liabilities0.000.200.00-0.170.000.160.00-0.000.180.000.00
Total Non-Current Liabilities0.500.200.040.040.172.320.020.02-0.000.180.000.00
Total Liabilities6.426.425.375.375.925.922.892.897.157.152.962.682.07
Stockholders' Equity
Common Stock0.060.060.040.040.000.010.000.000.000.000.030.010.00
Retained Earnings-141.18-141.18-111.12-111.12-151.38-88.47-59.16-59.16-49.48-49.48-111.23-69.72-60.58
Accumulated Other Comprehensive Income0.00-0.00-0.020.000.020.00-0.000.020.026.61
Additional Paid-in Capital161.78161.78125.40125.4086.8986.9071.4571.4548.7248.72106.8265.1550.95
Shares Outstanding-59.34-42.3242.03-42.03-42.03----
Total Stockholders' Equity20.9320.9314.5914.59-1.56-1.5612.3012.30-0.75-0.7510.580.261.97
Total Liabilities & Equity27.3527.3519.9719.974.364.3615.2015.206.406.4013.542.944.04

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About TuHURA Biosciences Balance Sheet

How much debt does TuHURA Biosciences have?

TuHURA Biosciences had total debt of $700.02K as of Mar 31, 2026, against $3.62M in cash and short-term investments. Its debt-to-equity ratio was 0.03. Total debt was $202.54K a year earlier.

What are TuHURA Biosciences's total assets?

TuHURA Biosciences reported total assets of $27.35M as of Mar 31, 2026, up 37.0% from $19.97M a year earlier. Total liabilities were $6.42M.

What is TuHURA Biosciences's shareholders' equity?

TuHURA Biosciences's shareholders' equity was $20.93M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition